首页> 外文OA文献 >NOVEL HIGH-POTENCY ORAL ANTIPLATELET DRUGS VERSUS CLOPIDOGREL IN PATIENTS UNDERGOING COMPLEX PERCUTANEOUS CORONARY INTERVENTION: RESULTS FROM A LARGE SINGLE-CENTER ALL-COMERS REGISTRY

【2h】

NOVEL HIGH-POTENCY ORAL ANTIPLATELET DRUGS VERSUS CLOPIDOGREL IN PATIENTS UNDERGOING COMPLEX PERCUTANEOUS CORONARY INTERVENTION: RESULTS FROM A LARGE SINGLE-CENTER ALL-COMERS REGISTRY

机译：正在进行复杂的经皮冠状动脉介入治疗的患者中新型高强度口服抗血小板药物与环磷酰胺：来自大型单中心全登记患者的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Giustino Gennaro; Baber Usman; Aquino Melissa; Dangas George; Kovacic Jason; Moreno Pedro; Swathi Roy; Krishnan Prakash; Sweeny Joseph; Mehran Roxana; Kini Annapoorna; Sharma Samin;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention Design and rationale for the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia study (PRODIGY). [J] . Valgimigli M, Campo G, Percoco G, The American heart journal . 2010,第5期

机译：平衡经皮冠状动脉介入治疗的所有患者抗内膜增生支架效能平衡后6个月和24个月氯吡格雷治疗的随机比较分级支架诱发的内膜增生研究（PRODIGY）后延长双抗血小板治疗的设计和原理。
2. Outcomes of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Receiving an Oral Anticoagulant and Dual Antiplatelet Therapy A Comparison of Clopidogrel Versus Prasugrel From the TRANSLATE-ACS Study [J] . Jackson Larry R., Ju Christine, Zettler Marjorie, JACC. Cardiovascular interventions . 2015,第14期

机译：接受口服抗凝和双重抗血小板治疗的经皮冠状动脉介入治疗的急性心肌梗死患者的疗效比较TRANSLATE-ACS研究的氯吡格雷与普拉格雷比较
3. Contraindications/special warnings and precautions for use of contemporary oral antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention - Insights from the GReek antiplatelet rEgistry (GRAPE) - [J] . AlexopoulosD., XanthopoulouI., DeftereosS., Circulation journal . 2014,第1期

机译：在接受经皮冠状动脉介入治疗的急性冠脉综合征患者中使用当代口服抗血小板治疗的禁忌症/特殊警告和注意事项-GReek抗血小板药理学（GRAPE）的见解-
4. Influence of Diabetes Mellitus in patients with Long Coronary Lesions Undergoing Percutaneous Coronary Interventions: Multicenter PCI Registry in Japan [C] . E. Saito, M. Hirose, T. Miyauchi, International Congress on Coronary Artery Disease . 2003

机译：经皮冠状动脉干预患者糖尿病患者糖尿病的影响：日本多中心PCI登记处
5. Procedural Volume in the Radial Percutaneous Coronary Intervention Era: An Analysis of the British Cardiovascular Intervention Society Registry [D] . Hulme, William J. 2018

机译：径向经皮冠状动脉干预时代的程序体积：英国心血管干预学会注册管理机构分析
6. Real-world use of ticagrelor versus clopidogrel in percutaneous coronary intervention-treated ST-elevation myocardial infarction patients: A single-center registry study [O] . Leia Hee, Oliver J. Gibbs, Joseph G. Assad, 2019

机译：替卡格雷与氯吡格雷在经皮冠状动脉介入治疗ST段抬高性心肌梗死患者中的实际应用：单中心注册表研究
7. NOVEL HIGH-POTENCY ORAL ANTIPLATELET DRUGS VERSUS CLOPIDOGREL IN PATIENTS WITH DIABETES MELLITUS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: RESULTS FROM A LARGE SINGLE-CENTER ALL-COMERS REGISTRY [O] . Giustino Gennaro, Baber Usman, Aquino Melissa, 2015

机译：接受经皮冠状动脉介入治疗的糖尿病患者中的新型高强度口服抗血小板药物与环磷酰胺：来自大范围单中心全科病登记的结果

NOVEL HIGH-POTENCY ORAL ANTIPLATELET DRUGS VERSUS CLOPIDOGREL IN PATIENTS UNDERGOING COMPLEX PERCUTANEOUS CORONARY INTERVENTION: RESULTS FROM A LARGE SINGLE-CENTER ALL-COMERS REGISTRY

著录项

相似文献

相关主题

期刊订阅